Astrana Health Net Profit Margin 2016-2026 | ASTH
Astrana Health net profit margin from 2016 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Astrana Health Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2026-03-31 | $3.53B | $0.03B | 0.82% |
| 2025-12-31 | $3.18B | $0.02B | 0.69% |
| 2025-09-30 | $2.90B | $0.01B | 0.31% |
| 2025-06-30 | $2.42B | $0.03B | 1.03% |
| 2025-03-31 | $2.25B | $0.04B | 1.56% |
| 2024-12-31 | $2.03B | $0.04B | 2.11% |
| 2024-09-30 | $1.72B | $0.06B | 3.60% |
| 2024-06-30 | $1.59B | $0.07B | 4.27% |
| 2024-03-31 | $1.45B | $0.06B | 4.27% |
| 2023-12-31 | $1.39B | $0.06B | 4.33% |
| 2023-09-30 | $1.33B | $0.04B | 3.32% |
| 2023-06-30 | $1.30B | $0.05B | 3.47% |
| 2023-03-31 | $1.22B | $0.04B | 3.61% |
| 2022-12-31 | $1.14B | $0.05B | 3.93% |
| 2022-09-30 | $1.05B | $0.06B | 5.55% |
| 2022-06-30 | $0.96B | $0.07B | 7.23% |
| 2022-03-31 | $0.86B | $0.07B | 8.13% |
| 2021-12-31 | $0.77B | $0.07B | 8.91% |
| 2021-09-30 | $0.76B | $0.07B | 9.26% |
| 2021-06-30 | $0.71B | $0.05B | 7.48% |
| 2021-03-31 | $0.70B | $0.05B | 6.73% |
| 2020-12-31 | $0.69B | $0.04B | 5.53% |
| 2020-09-30 | $0.69B | $0.04B | 5.08% |
| 2020-06-30 | $0.67B | $0.02B | 3.31% |
| 2020-03-31 | $0.63B | $0.02B | 3.02% |
| 2019-12-31 | $0.56B | $0.02B | 2.67% |
| 2019-09-30 | $0.49B | $0.01B | 1.02% |
| 2019-06-30 | $0.50B | $0.01B | 2.00% |
| 2019-03-31 | $0.49B | $0.01B | 1.83% |
| 2018-12-31 | $0.52B | $0.01B | 2.11% |
| 2018-09-30 | $0.53B | $0.04B | 7.68% |
| 2018-06-30 | $0.46B | $0.04B | 8.19% |
| 2018-03-31 | $0.42B | $0.04B | 8.77% |
| 2017-12-31 | $0.38B | $0.04B | 10.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.536B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |